Efficacy and Safety of Remdesivir in COVID-19 Positive Dialysis Patients
(1) Background: Immune compromised hemodialysis patients are more likely to develop COVID-19 infections, which increase the risk of mortality. The benefits of Remdesivir, despite less literature support on its effectiveness in dialysis patients due to renal toxicity, can outweigh the risks if prescr...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2022-01-01
|
| Serie: | Antibiotics |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/2079-6382/11/2/156 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|